Phenotypic Screening Deconvolution

Phenotypic Screening Deconvolution is a target deconvolution method that identifies the molecular targets of bioactive compounds discovered through phenotypic screening by integrating experimental and computational approaches to link observed cellular phenotypes to specific protein targets or pathways.

12

Publications

548

Citations

56

Authors

22

Institutions

Publications per year

2017–2026

4

Authors

56

  1. OE
    Ola Engkvist

    AstraZeneca (Sweden), Sweden

    2 publications · 135 citations

    2

    h-index

  2. EL
    Ellen L. Berg

    Stanford University, United States

    2 publications · 255 citations

    2

    h-index

  3. JY
    Jian Yang

    Chinese Academy of Sciences, China

    2 publications · 255 citations

    2

    h-index

  4. MA
    Mark A. Polokoff

    United States Military Academy, United States

    2 publications · 255 citations

    2

    h-index

  5. JM
    Julio Martín

    GlaxoSmithKline (Spain), Spain

    1 publications · 18 citations

    1

    h-index

1–5 of 56

Venues

  1. SLAS DISCOVERY

    3 publications · 77 citations

    3

    h-index

  2. Nature Biotechnology

    1 publications · 209 citations

    2

    h-index

  3. ACS Omega

    1 publications · 14 citations

    1

    h-index

  4. ACS Chemical Biology

    1 publications · 18 citations

    1

    h-index

  5. 1

    h-index

1–5